Advertisement
Advertisement
U.S. Markets open in 6 hrs 46 mins
Advertisement
Advertisement
Advertisement
Advertisement

American Funds 2060 Target Date Retirement Fund Class R-5E (RHKTX)

Nasdaq - Nasdaq Delayed Price. Currency in USD
Add to watchlist
14.21+0.36 (+2.60%)
At close: 08:00PM EDT
Advertisement
Full screen
Previous Close13.85
YTD Return-8.84%
Expense Ratio (net)0.55%
CategoryTarget-Date 2060+
Last Cap Gain0.00
Morningstar Rating★★★★★
Morningstar Risk RatingBelow Average
Sustainability Rating
Net Assets5.19B
Beta (5Y Monthly)1.38
Yield0.66%
5y Average ReturnN/A
Holdings Turnover3.00%
Last Dividend0.01
Average for CategoryN/A
Inception DateNov 20, 2015
  • GlobeNewswire

    Agile Therapeutics to Report First Quarter 2022 Financial Results and Provide Business Update on Thursday, May 12, 2022

    Live Conference Call and Webcast at 4:30 p.m. ETPRINCETON, N.J., May 03, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report first quarter 2022 financial results after the market close on Thursday, May 12, 2022. Following the release, the Company will host a live conference call and webcast at 4:30 p.m. ET to discuss the Company’s financial results and provide a business update. DateThursday, May 12, 2022Time4:30 p.m. ETW

Advertisement
Advertisement